Abstract:Hongjuan Liu, 1 Yanli Tang, 1 Quan Zhou, 1 Jing Zhang, 2 Xin Li, 1 Hui Gu, 1 Bohong Hu, 1 Yandeng Li 1 1 Changde Hospital, Xiangya School of Medicine, Central South University, Changde, 415000, People's Republic of China; 2 Lixian People's Hospital, Changsha Medical University, Lixian, 415500, People's Republic of China Correspondence: Bohong Hu; Yandeng Li, Email ; Objective: This study targeted elucidating the intricate correlation of the blood urea nitrogen (BUN)-to-albumin (BUN/Alb) ratio with adverse outcomes (AOs) at 3-month in acute ischemic stroke (AIS) cases within a Korean cohort. Methods: The cohort involved a comprehensive dataset of 1850 AIS cases from a South Korean hospital, spanning from January 2010 to December 2016. To discern the linear relationship of the BUN/Alb ratio with AOs in AIS cases, utilization of a binary logistic regression model (BLRM) was implemented. Additionally, it was attempted to utilize sophisticated statistical techniques, such as generalized additive models (GAMs) and smooth curve fitting methods, to unravel the nonlinear association of the BUN/Alb ratio with AOs in such patients. Results: The incidence of AOs was determined to be 28.49%, with the median BUN/Alb ratio being 3.85. After adjusting for a number of covariates, the BLRM disclosed that the linear association of BUN/Alb ratio with the risk of AOs particularly in AIS cases did not achieve statistical significance. However, a noticeable nonlinear relationship emerged, with an inflection point identified at 2.86. To the left of this inflection point, the relationship is not statistically significant. On the right side of the inflection point, there was a remarkable 9.47% rise in the risk of AOs (odds ratio (OR) = 1.09, 95% confidence interval (CI): 1.00, 1.19, P = 0.04). Conclusion: The outcomes illuminate the complex and nonlinear relationship of the BUN/Alb ratio with 3-month AOs in AIS cases. This study established a robust groundwork for the future research, underscoring the potential clinical utility of monitoring the BUN/Alb ratio to enhance the prognostic assessment and management of AIS cases. Keywords: blood urea nitrogen 1, albumin 2, stroke 3, adverse outcomes 4, cohort study 5 Stroke poses a formidable global health concern, occupying the position of the second fundamental etiology of mortality and the third most remarkable contributor to both death and long-term disability on a worldwide scale. 1,2 In particular, ischemic stroke represented a significant majority, comprising 62.4% of all newly diagnosed stroke cases in 2019, highlighting its predominant role in the overall epidemiology of cerebrovascular disorders. 1 Stroke exacts a formidable economic toll on nations and societal frameworks, particularly amplifying its impact in low- and middle-income regions. 2 Planning and providing quality acute stroke care services can reduce the burden of disease following stroke. 2 Therefore, it is vital to identify high-risk patients with poor prognosis in the acute phase of stroke and provide more efficacious treatment and care during hospitalization to improve their prognosis. Previous higher-quality studies have demonstrated that certain clinical biomarkers, such as natriuretic peptides, copeptin, procalcitonin, mannose-binding lectin, adipocyte fatty acid-binding protein, and cortisol are associated with acute ischemic stroke (AIS) prognosis. 3 However, the aforementioned parameters are not standard clinical biomarkers and are not readily accessible, highlighting the necessity of obtaining simple and practical indicators. Therefore, we have been looking for simple and easy-to-use indicators that can more accurately predict prognosis at 3 months after stroke. Our previous study 4 found that the blood urea nitrogen (BUN)-to-creatinine (BUN/Cr) ratio had a non-linear U-shaped relationship with AOs. BUN was negatively correlated with AOs when the BUN/Cr ratio was lower than 21.591. On the contrary, BUN/Cr ratio over 21.591 was positively correlated with AOs. However, BUN/Cr is considered to be a surrogate for plasma osmolality and may primarily reflect the status of renal function. The BUN/Alb ratio has been found to be an effective prognostic biomarker in recent years. It has exhibited remarkable predictive ability in acute kidney injury, 5 sepsis, 6–9 coronary heart disease (CHD), 10 traumatic brain injury, 11 idiopathic pulmonary arterial hypertension, 12 congestive heart failure, 13 aspiration pneumonia, 14 and other diseases. Renal function and nutritional status, as pivotal determinants o -Abstract Truncated-

Blood Urea Nitrogen to Left Ventricular Ejection Ratio as a Predictor of Short-Term Outcome in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Blood Urea Nitrogen (BUN) is independently associated with mortality in critically ill patients admitted to ICU

The association of blood urea nitrogen-to-creatinine ratio and in-hospital mortality in acute ischemic stroke patients with atrial fibrillation: data from the MIMIC-IV database

Prediction of prognosis in patients with nontraumatic intracranial hemorrhage using blood urea nitrogen-to-creatinine ratio on admission: a retrospective cohort study based on data from the medical information Mart for intensive care-IV database

Elevated BUN Upon Admission as a Predictor of in-Hospital Mortality Among Patients with Acute Exacerbation of COPD: A Secondary Analysis of Multicenter Cohort Study

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide and Glomerular Filtration Rate in Patients with Acute Heart Failure

Blood urea nitrogen variation upon admission and at discharge in patients with heart failure

Clinical impact of blood urea nitrogen, regardless of renal function, in heart failure with preserved ejection fraction

Relationship between blood urea nitrogen-to-creatinine ratio at hospital admission and long-term mortality in patients with acute decompensated heart failure

The association of blood urea nitrogen levels upon emergency admission with mortality in acute exacerbation of chronic obstructive pulmonary disease

Predictors of Long-Term Mortality in Patients with Acute Heart Failure.

Relationship between blood urea nitrogen to serum albumin ratio and short-term mortality among patients from the surgical intensive care unit: a population-based real-world study

The Neutrophil Percentage-to-Albumin Ratio as a New Predictor of All-Cause Mortality in Patients with Cardiogenic Shock

Association between admission heart rate and major adverse cardiovascular events in acute myocardial infarction participants with different left ventricular ejection fraction

The Interrelation of Blood Urea Nitrogen-to-Albumin Ratio with Three-Month Clinical Outcomes in Acute Ischemic Stroke Cases: A Secondary Analytical Exploration Derived from a Prospective Cohort Study

Novel Prognostic Predictor for Primary Pulmonary Hypertension: Focus on Blood Urea Nitrogen

Blood urea nitrogen to serum albumin ratio as a new prognostic indicator in critical patients with chronic heart failure

Prognostic significance of blood urea nitrogen/creatinine ratio in chronic HFpEF

Blood urea nitrogen to serum albumin ratio: a good predictor of in-hospital and 90-day all-cause mortality in patients with acute exacerbations of chronic obstructive pulmonary disease

Association between Albumin-Corrected Anion Gap and Mortality in Patients with Cardiogenic Shock

Association between lactate/albumin ratio and all-cause mortality in critical patients with acute myocardial infarction